Reena Kulkarni, Reshmi Pushpan, Srilakshmi C, Nayan J, Sarin N.S


COVID-19 is an ongoing pandemic characterized by a rapid spread and high virulence across the world. None of the conventional antimicrobial and chemotherapeutic agents including vaccines have been identified to be disease-specific for this illness. The swiftly changing and resistant nature of the virus augments an imperative need to explore novel pharmacotherapeutic agents, such as those involving herbal medicine. Ayurvedic pharmacopoeia offers wide range of botanicals, polyherbal and herbomineral formulations proven to be effective against viral diseases. This manuscript is an outcome of extensive literature search with Ayurveda background to identify few such botanicals that are adopted effectively in Indian community to curb the features of COVID 19. All of them possess anti-viral, immunomodulatory or both the activities established through in vitro and in vivo models. Further, compound formulations of Ayurveda comprising these medicinal plants that could be adapted at various stages of COVID-19 are discussed here. Considering future perspectives, real time clinical documentation conjoined with reverse pharmacology studies in the laboratory setup are the current need. In view of the global burden of the disease and the corresponding health expenditure vis-a-vis the community, there is an imperative need to consider using these suggested plants which are easily available, cost effective and adaptable into multiple dosage forms to suit different age groups and patients with underlying comorbidities. Considering the gravity of the disease and its massive impact on the society, we exhort upon policy makers to propagate their cultivation, preservation and promotion as medicament and usage as home remedies. Thus it aids in self-reliance within communities to fight against COVID-19.

Keywords: Ayurveda, Antiviral, Botanicals, COVID-19, Immunomodulatory, Sannipataja Jwara

Running title: Introducing few Ayurvedic botanicals helpful in COVID 19

Full Text:



Wikipedia. Severe acute respiratory syndrome coronavirus 2.Available from:–20_coronavirus_pandemic [Last accessed on 2020 May 23].

World Health Organization. Coronavirus disease (COVID-19) pandemic. Available from: [Last accessed on 2020 May 23]

The SARS-CoV-2 outbreak: What we know Di Wu1, Tiantian Wu2, Qun Liu1, Zhicong Yang1,* International Journal of Infectious Diseases 94 (2020) 44–48 [Last accessed on 2020 May 23]

"Casos de Coronavirus COVID-19 en Panamá". Available from:

coronavirus-covid19. Ministerio de Salud de la RepúblicadePanamá(in Spanish).[Retrieved on 29 April 2020].

Hopkins C. "Loss of sense of smell as marker of COVID-19 infection".Available from:, Nose and Throat surgery body of United Kingdom. [Retrieved on 28 March 2020].

Centers for Disease control and Prevention."Coronavirus Disease 2019 (COVID-19)—Symptoms”. Available from [Retrieved on 21 March 2020].

Centers for Disease control and Prevention."Interim Clinical Guidance for Management of Patients withConfirmed Coronavirus Disease (COVID-19)". Available from[Retrieved on 11 April 2020].

World Health Organization. Situation Reports. Available from:[Last accessed on 2020 May 23].

Nishteshwar K. KoppulaHemadri. 1st ed. Delhi: Chaukhambha Sanskrit Pratishtan; 2010.

Nayampalli S, Ainapure SS, Nadkarni PM. Study of antiallergic acid Bronchodilator effects of Tinosporacordifolia. Indian J Pharm.1982;14:64–66.

Zhao TF, Wang X, Rimando AM et al. Folkloric medicinal plant: Tino sporasagit tatavar. cravaniana and Mohoniabealei. Planta Med. 1991;57:505–3. [PubMed: 1798808]

Kalikar MV, Thawani VR, Varadpande UK et al. Immunomodulatory effect of Tinosporacordifolia extract in human immuno-deficiency virus positivepatients.Indian J Pharmacol2008; 40:107–10.

Thatte UM, Dahanukar SA. Immunotherapeutic modification of experimental infections.Ind Med plants Phytoter Res 1989;3:43-9.

Sharma U, Bala M, Kumar N, Singh B et al.Immunomodulatory active compounds from Tinosporacordifolia. JEthnopharmacol 2012b; 141(3): 918-26.

Pan L, Terrazas C, Lezama-Davila CM et al. Cordifolide A, a sulfur-containing clerodanediterpene glycoside from Tinosporacordifolia. Org Lett 2012;14(8): 2118-21.

Chulet R, Pradhan P. A review on Rasayana.Phcog Rev. 2009;3:229–34.

Sharma V, Pandey D. Protective role of Tinosporacordifolia against lead-induced hepatotoxicity. Toxicol Int. 2010;17:12–7.[PMCID: PMC2964743] [PubMed: 21042467]

Singh SS, Pandey SC, Srivastava S et al.Chemistry and medicinal properties of Tinosporacordifolia(Guduchi). Indian J Pharm 2003; 35(2): 83-91.

Singh DP, Awasthi H, Luqman S et al. Hepatoprotectiveeffect of a polyherbal extract containingAndrographisPaniculata,TinosporacordifoliaandSolanumNigrumagainstparacetamolinduced hepatotoxicity. Pharmacogn Mag 2015; 11(Suppl 3):S375.

Bhat PM, Umale H, Lahankar M. Amalaki: A review on functional and pharmacological properties. Journal of Pharmacognosy and Phytochemistry. 2019;8(3):4378-82.

Nadkarni, K.M. Indian MateriaMedica. Reprint ed. Bombay: Popular Prakashan Private, Bombay;2013.

Kulkarni R, Shetty SK, Rajarajeshwari NM et al. Rasayana herbs of ayurveda to treat age related cognitive decline: An update. Pharmacognosy Journal. 2016;8(5).

Suresh K, Vasudevan DM. Augmentation of murine natural killer cell and anti-body dependent cellular cytotoxicity activities by Phyllanthusemblica, a new immunomodulator. Journal of Ethnopharmacology. 1994;44(1):55-60.

Mathur R, Sharma A, Dixit VP et al. Hypolipidaemic effect of fruit juice of Emblicaofficinalisin cholesterol-fed rabbits. Journal of Ethnopharmacology. 1996;50(2):61-68.

Grover IS, Kaur S. Effect of EmblicaofficinalisGaertn. (Indian gooseberry) fruit extract on sodium azide and 4-nitro-O-phenylenediamine induced mutagenesis in Salmonella typhimurium. Chemical Abstract 111, 17230h. 1989; 27(3):207-9.

Saha S, Verma RJ. Antioxidant activity of polyphenolic extract of TerminaliachebulaRetzius fruits. Journal of taibah university for science. 2016 Oct 1;10(6):805-12.

S.-H.Kim, C.-D. Jun, K. Suk et al., “Gallic acid inhibits histaminerelease and pro-inflammatory cytokine production in mast cells,” Toxicological Sciences, vol. 91, no. 1, pp. 123–131, 2006.

Afshari AR, Sadeghnia HR, Mollazadeh H. A review on potential mechanisms of Terminaliachebula in Alzheimer’s disease.Advances in pharmacological sciences. 2016;2016.

Antiviral activity of Terminalia.Natural product radiance vol.2 (1); 2003: 30.

Lin LT, Chen TY, Lin SC et al.Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry.BMC microbiology. 2013 Dec;13(1):187.

Senthilkumar GP, Subramanian S. Evaluation of antioxidant potential of Terminaliachebula. Fruits studied in streptozotocin-induced diabetic rats. Pharmaceutical Biology. 2007 Jan 1;45(6):511-8.

Aher VD, Kumar A. Immunomodulatory effect of alcoholic extract of Terminaliachebula ripe fruits. Journal of Pharmaceutical Sciences and Research. 2010 Sep 1;2(9):539.

A.H.N. Jeong, C.Y. Kim, J.S. Lee et al. Inhibition of HIV-1 integrase by galloyl glucoses fromTerminaliachebulaandflovonol glycoside gallates from Euphorbia pekinensis.PlantaMedica. 68 : 457-9 (2002).

Suthienkul et al. Retroviral reverse transcriptase inhibitory activity in Thai Herbsand Species. Screening with moloney murine leukemia viral enzyme.South-EastAsian Journal Trop. Med., Public Health.24 (4) : 751-5 (1993).

V. Badmaev, M. Nowakowski. Protection of epithelial cells against influenza Avirus by plant derived biological response modifier Ledretan-96. Phytother.Res.,44(4) : 245-9 (2000).

M. Kurowa, K. Nagasaka, T. Hirabayashi et al. Efficacy of traditional herbalmedicines in combination with acyclovir against Herpes Simplex Virus-1 infection invitroandin vivo. Antiviral Res., 27 (1-2) : 19-37 (1995).

Ma H, Diao Y, Zhao D et al. A new alternative to treat swine influenza A virus infection: Extracts from TerminaliachebulaRetz. Afr J Microbiol Res 2010;4(6):497-9.

Chattopadhyay RR, Bhattacharyya SK. Terminaliachebula: An update. Pharmacognosy Reviews. 2007;1(1).

L.I.C. Tang, A.P.K.Ling, R.Y.Koh et al “Screeningofanti-dengue activity in methanolic extracts of medicinal plants,” BMC Complementary and Alternative Medicine,vol.12,article3,2012.

S.Fangkham,T.Ekalaksananan,C. Aromdeeetal., “The effect of andrographolide on Humanpapilloma virus type16 (HPV16) positive cervical cancer cells (SiHa),” International Journal of InfectiousDiseases,vol.16,supplement1,p.e80,2012.

C. Aromdee, S. Suebsasana, T. Ekalaksananan et al, “Stage of action of naturally occurring andrographolides and their semisynthetic analogues against herpessimplexvirustype1invitro,”PlantaMedica,vol.77,no. 9,pp.915–921,2011.

J.-X.Chen,H.-J.Xue,W.-C.Ye et al., “Activity of andrographolide and its derivatives against influenza virus invivo and in vitro,” Biological and Pharmaceutical Bulletin, vol. 32, no. 8, pp.1385–1391,2009.

V.L.N.Reddy, S. M. Reddy, V. Ravikanth et al., “A new bisandrographolideetherfromAndrographispaniculataneesandevaluationofanti-HIVactivity,” Natural Product Research,vol. 19,no.3,pp.223–230,2005.

Agarwal R.R. and Dutt S.S., Chemical examination of punarnava or Boerhaaviadiffusa Linn. Isolation of an alkaloid punarnavine., Chemical Abstract, 30(2), 3585 (1936)

Surange S.R. and Pendse G.S., Pharmacognostic study of roots of Boerhaavia d. (Punarnava)., Journal of Research in Indian Medicine, 7, 1 (1972)

Kadota S., Lami N., Tezuka Yet al .Constituents of the roots of Boerhaaviadiffusa Linn. I. Examination of sterols and structures of new rotenoids (boeravinones A and B)., Chemical and Pharmaceutical Bulletin., 37(12), 3214-3220 (1989)

Lami N., Kadota S., Tezuka Y et al .Constituents of the roots of Boerhaaviadiffusa Linn. II. Structure and stereochemistry of a new rotenoidboeravinoneC2., Chemical and Pharmaceutical Journal., 38(6), 1558-1562 (1990)

Ahmad K. and Hossain A., Isolation, synthesis and biological action of hypoxanthine-9- Larabinofuranoside, Journal of Agricultural and Biological Sciences., 11, 41 (1968)

Mishra A.N. and Tiwari H.P., Constituents of the roots of Boerhaavia diffuse, Phytochemistry, 10, 3318 (1971)

Jain G.K. and Khanna N.M., Punarnavoside: A new antifibrinolytic agent from Boerhaaviadiffusa Linn., Indian Journal of Chemistry., 28(B), 163-166 (1989)

Chude MA, Orisakwe OE, Afonne OJ et al. Hypoglycaemic effect of the aqueous extract of Boerhaviadiffusa leaves. Indian Journal of Pharmacology. 2001 May 1;33(3):215

Verma H.N., Awasthi L.P. and Saxena K.C.., Isolation of virus inhibitor from the root extract of Boerhaaviadiffusa inducing systemic resistance in plants., Canadian Journal of Botany., 57, 1214-18 (1979)

Chopra R.N., Ghosh S., Dey P et al .Pharmacology and therapeutics of Boerhaaviadiffusa (punarnava), Indian Medical Gazette. 68, 203-08 (1923)

Mahesh AR, Kumar H, Ranganath MK et al. Detail Study on Boerhaaviadiffusa plant for its medicinal importance-A Review. Res J Pharm Sci. 2012 Sep;1(1):28-36.

Gaitonde BB, Kulkarni HJ, Nabar SD (1974) Diuretic activity of punarnava (Boerhaaviadiffusa). Bull HaffkineInst 2:24

Jagetia, G.C., Aggarwal, B.B., 2007. “Spicing up” of the immune system by curcumin. J. Clin. Immunol. 27, 19–35.

P.LaColla,E.Tramontano,C.Musiu et al , “Curcumin-like derivatives with potent activityagainstHIV-1integrase:synthesis,biologicalevaluation andmolecularmodeling,” AntiviralResearch,vol.37,no.3,pp. 57–57,1998.

Anand,A.B.Kunnumakkara,R.A.Newman et al ,“ Bioavailability ofcurcumin:problemsandpromises,”MolecularPharmaceutics,vol.4,no.6,pp.807–818,2007

D.-Y. Chen, J.-H.Shien, L. Tiley et al., “Curcumin inhibits influenzavirusinfectionandhaemagglutinationactivity,”Food Chemistry,vol.119,no.4,pp.1346–1351,2010.

S.B.Kutluay,J.Doroghazi,M.E.Roemer et al , “Curcumininhibitsherpessimplexvirusimmediate-earlygeneexpressionbyamechanismindependentofp300/CBPhistone acetyltransferaseactivity,”Virology,vol.373,no.2,pp.239–247, 2008.

X. Si, Y. Wang, J. Wong et al, “Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackie virus B3 replication,” Journalof Virology,vol.81,no.7,pp.3142–3150,2007.

H.J.Kim,H.S.Yoo,J.C.Kimetal.,“AntiviraleffectofCurcumalongaLinnextractagainsthepatitisBvirusreplication,”Journal ofEthnopharmacology,vol.124,no.2,pp.189–196,2009.

K. Kim, K. H. Kim, H. Y. Kim et al,“CurcumininhibitshepatitisCvirusreplicationvia suppressing the Akt-SREBP-1 pathway,” FEBS Letters, vol. 584, no.4,pp.707–712,2010.

C.S.DivyaandM.R.Pillai,“Antitumoractionofcurcumininhumanpapillomavirusassociatedcellsinvolvesdownregulation ofviraloncogenes,preventionofNFkBandAP-1translocation, andmodulationofapoptosis,”MolecularCarcinogenesis,vol.45, no.5,pp.320–332,2006.

B.K.PrustyandB.C.Das,“Constitutiveactivationoftranscription factor AP-1 in cervical cancer and suppression of human papillomavirus(HPV)transcriptionandAP-1activityinHeLa cellsbycurcumin,”InternationalJournalofCancer,vol.113,no. 6,pp.951–960,2005.

K.Dutta,D.Ghosh,andA.Basu,“Curcuminprotectsneuronal cells from japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulationofubiquitin-proteasomesystem,”JournalofNeuroimmune Pharmacology,vol.4,no.3,pp.328–337,2009.

Kurup VP, Barrios CS. Immunomodulatory effects of curcumin in allergy. Molecular nutrition & food research. 2008 Sep;52(9):1031-9.

Yeh, C.-H., Chen et al, 2005. Inhibition of NFkappaB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion. J. Surg. Res. 125, 109–116.

Toda, S., Miyase, T., Arichi, H et al., Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa. Chem. Pharm. Bull. 1985, 33,1725–1728.

Mortellini, R., Foresti, R., Bassi, R et al., Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress.FreeRadic.Biol.Med.2000,28,1303–1312.

Shityakov S, Bigdelian E, Hussein AA, et al. Phytochemical and pharmacological attributes of piperine: A bioactive ingredient of black pepper. European journal of medicinal chemistry. 2019 Apr 5.

Tripathi DM, Gupta N, Lakshmi V et al. Antigiardial and immunostimulatory effect of Piper longum on giardiasis due to Giardia lamblia. Phytother Res 1999; 13:561−5.

Devan P, Bani S, Suri KA. Immunomodulation exhibited by piperinic acid through suppression of proinflammatory cytokines. IntImmunopharmacol 2007; 7:889-99

Khajuria A, Thusu N, Zutshi U. Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomedicine 2002;9:224−31.

Ali AM, Alam NM, Yeasmin MS et al. Antimicrobial screening of different extracts of Piper longum Linn. Res J Agr Bio Sci 2007;3:852−7.

Priya N. C, P. SaravanaKumari. Antiviral Activities and Cytotoxicity Assay of Seed Extracts of Piper longumandPipernigrum on Human Cell Lines. Int. J. Pharm. Sci. Rev. Res. 2017; 44(1): 197-202.

Chanda D, Shanker K, Pal A et al. Safety evaluation of Trikatu, a generic Ayurvedic medicine in Charles foster rats. J ToxicolSci 2009;34:99−108.

Pattanaik S, Hota D, Prabhakar S et al. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy. Phytother Res 2006;20: 683−6.

Bukhari IA, Pivac N, Alhumayyd MS et al (2013) Theanalgesic and anticonvulsant effects of piperine in mice. See comment inPubMed Commons below J PhysiolPharmacol 64: 789-794.

Sharma S, Kalia NP1, Suden P2 et al. (2014)Protective efficacy of piperine against Mycobacterium tuberculosis. Seecomment in PubMed Commons below Tuberculosis (Edinb) 94: 389-396.

Riaz H, Begum A, Raza SA et al. Antimicrobial property and phytochemical study of ginger found in local area of Punjab, Pakistan. International Current Pharmaceutical Journal. 2015 Jun 6;4(7):405-9.

Kumar G, Karthik L, Rao KB. A review on pharmacological and phytochemical properties of Zingiberofficinale Roscoe (Zingiberaceae).Journal of Pharmacy Research. 2011 Sep;4(9):2963-6.

San Chang J, Wang KC, Yeh CF et al. Fresh ginger (Zingiberofficinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. Journal of ethnopharmacology. 2013 Jan 9;145(1):146-51.

Hori Y, Miura T, Hirai Y et al. Pharmacognostic studies on ginger and related drugs—part 1: five sulfonated compounds from Zingiberis rhizome (Shokyo). Phytochemistry. 2003 Feb 1;62(4):613-7.

Carrasco FR, Schmidt G, Romero AL et al. Immunomodulatory activity of Zingiberofficinale Roscoe, Salvia officinalis L. and Syzygiumaromaticum L. essential oils: evidence for humor and cell mediated responses. Journal of Pharmacy and Pharmacology. 2009 Jul;61(7):961-7.

Weidner MS, Sigwart K. The safety of a ginger extract in the rat. Journal of ethnopharmacology. 2000 Dec 1;73(3):513-20

Hatano T, Shintani Y , Shiota S et al. Phenolic constituents of licorice. VIII. Structures of glicophenone and glycoisoflavanonem and effects of licorice, phenolics on Methicillin- resistant Staphylococcus aureus. Chem Pharm Bull. 2000;48:1286–92. [PubMed: 10993226]

Ishii Y , Fuji Y . Effects of FM 100, a fraction of licorice root on serum gastrin concentration in rats and dogs. Jpn J Pharmacol. 1982;32:23–7. [PubMed: 7087261]

Kuroda M, Mimaki Y , Sashida Y et al. Phenolics with PPAR- Ligand binding activity obtaind from Licorice (Glycyrrhizauralensis roots) and ameliorative effects of Glycyrin on genetically diabetic KK-Ay mice. Bioorg Med ChemLett. 2004;13:4267–72. [PubMed: 14643306]

Badam L (1997) In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus. J Commun Dis 29:91–99

De Clercq E (2000) Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med Res Rev 20:323–349

Badam L (1994) In vitro studies on the effect of glycyrrhizin from Glycyrrhizaglabra on some RNA and DNAviruses. Indian J Pharmacol 26:194–199

Hayashi J, Kashiwagi S, Noguchi A et al. Combination therapy of glycyrrhizin withdrawal and human fibroblast interferon for chronic hepatitis B. First Asia-Pacific Congress of Medical Virology 1988;62:6-11.

Lalita B. In vitro studies on the effect of glycyrrhizin from Indian Glycyrrhizaglabra Linn on some RNA and DNA viruses.Indian Journal of Pharmacology. 1994 Jul 1;26(3):194.

Arora R, Chawla R, Marwah R, et al (2011) Potential of complementary and alternative medicine in preventive management of novel H1N1 Flu (Swine Flu) pandemic: thwarting potential disasters in the bud. Evid Based Complement Alternat Med 2011:1–16

Abe M, Akbar F, Hasebe A et al. Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis. Journal of gastroenterology. 2003 Oct 1;38(10):962-7.

Badam L (1994) In vitro studies on the effect of glycyrrhizin from Glycyrrhizaglabra on some RNA and DNAviruses. Indian J Pharmacol 26:194–199

Blatina LA (2003) Chemical modification of glycyrrhizic acid as a route to bioactive compounds for medicine. Curr Med Chem 10:155–171.

Qian-Cutrone, J., 1996. Niruriside, a new HIV REV/RRE binding inhibitor from Phyllanthusniruri . Journal of Natural Products 59 (2), 196-199.

Adair R.S. Santos., Joa˜o B. Calixto et al., (2000) Antinociceptive properties of extracts of new species of plants of the genus Phyllanthus (Euphorbiaceae). J of Eth phar, 72, 229–238.

Huang, R. L., Huang, Y. L., Ou, J. C., et al (2003) Screening of 25 compounds isolated from Phyllanthus species for anti-human hepatitis B virus in vitro. Phytother. Res. 17: 449–453.

Thyagarajan SP et al. Effect of Phyllanthusamarus on chronic carriers of hepatitis B virus. Lancet 1988; 332: 764–766. 70. Jb H. Antiviral compounds from plants. Boca Raton, Ann Arbor, Boston: CRC Press, 1990.

Jb H. Antiviral compounds from plants. Boca Raton, Ann Arbor, Boston: CRC Press, 1990.

Unander, D.W., Webster, G.L., Blumberg, B.S., 1995. Usage and bioassays in Phyllanthus (Euphorbiaceae). IV. Clustering of antiviral uses and other effects. J. Ethnopharmacol. 45, 1–18.

Lee NY, Khoo WK, Adnan MA et al. The pharmacological potential of Phyllanthusniruri.Journal of pharmacy and pharmacology. 2016 Aug;68(8):953-69.

Lee SH et al. Effects of cocktail of four local Malaysian medicinal plants (Phyllanthus spp.) against dengue virus 2. BMC Complement Alter Med 2013; 13: 192.

Scarfiotti et al., 1997; Adallu and Radhika, 2000; Hemalatha et al., 2006;Naidu et al., 2006; Mahima et al., 2012; Dhama et al., 2013a

Bisht P, Rawat V (2014) Antibacterial activity of Withaniasomnifera against Gram-positive isolates from pus samples. Ayu 35:330

Arora S, Dhillon S, Rani G, Nagpal A (2004) The in vitroantibacterial/synergistic activities of Withaniasomnifera extracts. Fitoterapia 75:385–388

Iuvone, T., G. Esposito, F. Capasso et al, 2003. Induction of nitric oxide synthatase expression by Withaniasomnifera in macrophages. Life Sci., 72: 1617-1625.

Rastogi, R.P. and B.N. Mehrotra, 1998. Compendium of Indian Medicinal Plants. 5th Edn., Vol. 6, Central Drug Research Institute, New Delhi, India, Pages: 549.

BhushanPatwardhanet al. Ayurveda rasayana in prophylaxis of COVID-19; CURRENT SCIENCE, VOL. 118, NO. 8, 25 APRIL 2020

Kirtikar KR and Basu BD. Indian medicinal plants.2nd ed. Volume III. Dehradun: International Book Distributors 1999: 1783-1787.

Ratan L , Meenu B, Anju D et al - anatomical and physicochemical studies of dried seeds of Daturafastuosa Linn. . IRJP 2011; 2 (3): 208-212.

Anonymous. Schedule E-1 of Drugs and Cosmetics Act-1940 and Rules-1945, List of Poisonous Substances under Ayurveda System of Medicine, Government of India, New Delhi.

Yamazaki Z, Tagaya I. Antiviral effects of atropine and caffeine. J Gen Virol 1980;50:429-31.

Alarcon B, Gonzalez ME, Carrasco L. Antiherpesvirus action of atropine. Antimicrob Agents Chemother 1984;26:702-6.

JadavjiTrikamjiAcharya, editor (1st edition) CharakaSamhita by Agnivesa revised by Charaka and Dridabala, Commentary of Chakrapanidutta. Vimanasthana; Janapadodhwamsavimanam: Chapter 3, Verse. 6.

Acharya JT, editor, (Reprint ed.). Charakasamhita of Agnivesha, ChikitsaSthana; JwarachikitsaAdhyaya: Chapter 3, Verse 92. Varanasi: ChowkhmabhaOrientalia, 2015;406.

Acharya JT, editor, (Reprint ed.). Charakasamhita of Agnivesha, ChikitsaSthana; JwarachikitsaAdhyaya: Chapter 3, Verse 101. Varanasi: ChowkhmabhaOrientalia, 2015;406.

Sushruta, SushrutaSamhitaaNidaanaSthaana 5/33-4, with NyayachandrikaPanjika of srigayadasa commentary, edited by VaidyaYadavajiTrikamjiAachaarya, ChaukhambaSurbharatiPrakashana, Varanasi, reprint edition 2013, 289

Kerala Government Ayurveda Medical officer’s Federation. Ayurvedic strategies for the prevention, mitigation and. Rehabilitation of covid-19 in kerala. Action plan. Available from:[last accessed on 2020 may 23].

Vagbatta, Ashtang Hridya, Vidvanamanoranjini Hindi Commentry by Pt. Kashinath Shastri, edited by Pandit Harisadashiva shastri. chikitsasthana, 1/163-64. Varanasi: Krishnadas Academy; 1194, 572.

Anonymous, The Ayurvedic Formulary of India, Part-I, First edition, Government of India, Ministry of Health and Family Planning, Department of Health, Published by Government Of India Press, controller of Publications Delhi-1978, Section-12, 12:18, page-148, pp-324.

Sahasrayoga translated by Dr. D. B. Pandithrao, 1st Edition, CCRAS, Ayush Division, New Delhi, 2011, Gutika prakarana-123, Page-160, PP-621.

Sahasrayoga translated by Dr. D. B. Pandithrao, 1st Edition, CCRAS, Ayush Division, New Delhi, 2011, Kashaya prakarana-13, Page-03, PP-621.

Pandit Sri Lalacandrajivaidya, shreeGovindadasasenaBhaishajyaratnavali, Published by MotilalBanarasidas, NewDelhi, 1997, Hikka-swsadhikara:85-87, page-288, PP-832

Pandit Sri Lalacandrajivaidya, shreeGovindadasasenahaganlal Shah, MotilalBanarasidas, NewDelhi, 1997, Vajikaradhikara:286, page-799-, PP-832

Sahasrayoga DR, Sharma D. KashayaPrakarana: 34. Varanasi, ChaukhambaSanskritSansthan. 2012.

VaidyapanditHariprapannaji, Rasyogasagara, Volume-II, Publication: ChowkhambaKrishnadas Academy, Varanasi, 2010, Page-582, PP-704.

Compiled by vaidyaNagindasShah, Bharatabhaishajyaratnakara, Volume-V, Published by B. Jain Publishers, New Delhi, 1995, 5/8659, Page-503, PP-864.

World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization; 2020.Available from Available from:[Last accessed on 2020 May 27].


  • There are currently no refbacks.

                                                   International Journal of AYUSH (Ayurveda, Yoga, UnaniSiddha and Homeopathy)